Dow Up0.06% Nasdaq Up0.02%

Celgene Corporation (CELG)

-NasdaqGS
95.06 Down 0.60(0.62%) 12:43PM EDT - Nasdaq Real Time Price
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 1,872,700   1,730,000   1,755,900   1,674,400  
Cost of Revenue98,900  86,100  92,800  86,200  
Gross Profit 1,773,800   1,643,900   1,663,100   1,588,200  
Operating Expenses
Research Development456,900  713,700  731,200  584,500  
Selling General and Administrative491,800  494,100  448,700  448,700  
Non Recurring900  8,600  91,700  33,700  
Others65,300  65,700  65,700  65,700  
Total Operating Expenses1,014,900  1,282,100  1,337,300  1,132,600  
Operating Income or Loss 758,900   361,800   325,800   455,600  
Income from Continuing Operations
Total Other Income/Expenses Net(10,500)(200)(78,500)10,400  
Earnings Before Interest And Taxes748,400  361,600  247,300  466,000  
Interest Expense41,600  29,300  30,100  24,000  
Income Before Tax706,800  332,300  217,200  442,000  
Income Tax Expense109,000  52,600  2,800  69,500  
Minority Interest -   -   -   -  
Net Income From Continuing Ops597,800  279,700  214,400  372,500  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 597,800   279,700   214,400   372,500  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 597,800   279,700   214,400   372,500  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.